share_log

Needham Reiterates Buy on RxSight, Maintains $64 Price Target

Moomoo 24/7 ·  Apr 11 05:55

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $64 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment